Minnesota · 2025-2026 Regular Session · Bill
SF 205: Antineoplastic cancer treatment prior authorization prohibition
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
SF 205 is a bill introduced in the Minnesota Senate on January 16, 2025. According to its official title, it concerns: Antineoplastic cancer treatment prior authorization prohibition. Primary sponsor: Lindsey Port (Democratic-Farmer-Labor). It lists 3 additional sponsors. Most recent recorded action (March 10, 2025): Comm report: To pass as amended and re-refer to Health and Human Services.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Sponsors
Sponsors by party (alphabetical): Democratic-Farmer-Labor 4
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Lindsey Port | Primary sponsor | Democratic-Farmer-Labor | Senate | 55 |
| Liz Boldon | Co-sponsor | Democratic-Farmer-Labor | Senate | 25 |
| Alice Mann | Co-sponsor | Democratic-Farmer-Labor | Senate | 50 |
| Erin Maye Quade | Co-sponsor | Democratic-Farmer-Labor | Senate | 56 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Comm report: To pass as amended and re-refer to Health and Human Services
- Referred to Commerce and Consumer Protection
- Introduction and first reading